Algernon Pharmaceuticals Market Cap

Algernon Pharmaceuticals has a market cap or net worth of $1.67 million as of April 25, 2025. Its market cap has increased by 51.38% in one year.

Market Cap

1.67M

Enterprise Value

1.41M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.05

Market Cap Chart

Since February 1, 2016, Algernon Pharmaceuticals's market cap has decreased from 12.66M to 1.67M, a decrease of -86.79%. That is a compound annual growth rate of -19.68%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2025	1.67M	25.85%
Dec 31, 2024	1.33M	38.32%
Dec 29, 2023	960.22K	-74.54%
Dec 30, 2022	3.77M	-30.49%
Dec 31, 2021	5.43M	-77.97%
Dec 31, 2020	24.63M	709.53%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.67B
SS Innovations International	1.66B
Nika Pharmaceuticals	1.02B
Veradigm	704.15M
Northwest Biotherapeutics	497.89M
Elite Pharmaceuticals	437.70M
Glass House Brands	387.66M
CytoDyn	293.81M

Market Cap Rankings